Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

2016165 citationsJournal Articlehybrid Open Access

Authors

Bill & Melinda Gates Foundation, United States Agency for International Development, Global Alliance for Tuberculosis Drug Development.

Good health and well-being

Published in: The Lancet Infectious Diseases

Volume 16, Issue 10, pp. 1185-1192

Field-Weighted Citation Impact: 18.73